trimipramine (Q423498)

trimipramine (English)

3 October 2016

chemical formula

C₂₀H₂₆N₂

1 reference

trimipramine (English)

3 October 2016

canonical SMILES

CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C

1 reference

trimipramine (English)

World Health Organisation international non-proprietary name

3 October 2016

trimipramine (English)

1 reference

Trimipramine (English)

medical condition treated

19 January 2016

1 reference

significant drug interaction

13 December 2016

isocarboxazid

1 reference

High-priority drug–drug interactions for use in electronic health records

phenelzine

1 reference

High-priority drug–drug interactions for use in electronic health records

procarbazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(±)-deprenyl

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

guanfacine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lithium

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

geniospasm

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mental status change

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hyperthermia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

hypertension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

tachycardia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-nefopam

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

allomnesia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

hypotonia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Delirium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sertraline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bupropion

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Solute carrier family 6 member 3

enzyme inhibitor

1 reference

Solute carrier family 6 member 2

17 August 2016

enzyme inhibitor

1 reference

solute carrier family 6 member 4

17 August 2016

enzyme inhibitor

1 reference

Australian pregnancy category C

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

selective serotonin reuptake inhibitor

1 reference

5 March 2018

adrenergic uptake inhibitors

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

D014299

15 March 2018

tricyclic antidepressant

1 reference

InChI=1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3

Medical Subject Headings

15 March 2018

Trimipramine

0 references

Identifiers

InChI

1 reference

trimipramine (English)

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

3 October 2016

InChIKey

2 references

trimipramine (English)

3 October 2016

ChEBI release 2020-09-01

1 reference

trimipramine (English)

3 October 2016

1 reference

Trimipramine (English)

3 October 2016

1 reference

trimipramine (English)

3 October 2016

Reaxys registry number

1321466

1 reference

trimipramine (English)

3 October 2016

ChEBI ID

9738

mapping relation type

1 reference

trimipramine (English)

3 October 2016

1 reference

splash10-0002-0090000000-683044c8af33df070967

TRIMIPRAMINE (English)

3 October 2016

1 reference

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA000608

0 references

MSBNK-Waters-WA000609

0 references

MSBNK-Waters-WA000610

0 references

MSBNK-Waters-WA000611

0 references

MSBNK-Waters-WA000612

0 references

MSBNK-Waters-WA000613

0 references

SPLASH

0 references

splash10-0udj-1960000000-2c69c2591b0ff915ccc2

0 references

splash10-0zfr-3920000000-7c68e89e7f53026fdb80

0 references

splash10-0zfr-4930000000-f1fe2a4f61bfbec6d778

0 references

splash10-0pb9-7920000000-b085a14dd7e5d88d4922

0 references

splash10-0a4l-9810000000-b67a0e6866c4bcb27488

0 references

splash10-0002-0090000000-90da643ba602b4854ad4

0 references

splash10-0udj-1960000000-953dd8f5d50ce412ae55

0 references

splash10-0zfr-2920000000-493d39be6384cb3b09d4

0 references

splash10-0zfr-4920000000-02c877be6bc360fbe70e

0 references

splash10-0pb9-6920000000-eb3878e47d12e4792744

0 references

splash10-0a4l-8910000000-5341bd1feea3e6a75bc8

0 references

splash10-0udi-0900000000-875e7a40df38e129227c

0 references

splash10-0a4m-5790000000-53c724efbeeb45818f39

0 references

DSSTox substance ID

DTXSID8023715

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

DTXCID003715

0 references

EC number

212-008-3

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.010.917

27 December 2018

ECHA Substance Infocard ID

Trimipramine (English)

quotation

CAS no.: 739-71-9 (English)

100.010.917

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.010.917

27 December 2018

Trimipramine (English)

quotation

CAS no.: 739-71-9 (English)

1 reference

Trimipramine (English)

publication date

17 November 2015

1 reference

trimipramine (English)

3 October 2016

Trimipramine

0 references

0 references

1 reference

26 February 2018

1 reference

Trimipramine (English)

Human Metabolome Database ID

3 October 2016

HMDB0014864

1 reference

based on heuristic

inferred from InChIKey

1 reference

Trimipramine (English)

MedlinePlus drug identifier

3 October 2016

a602010

0 references

PatientsLikeMe treatment ID

0 references

1 reference

TRIMIPRAMINE (English)

19 January 2016

0 references

1 reference

1 reference

trimipramine (English)

3 October 2016

1 reference

6 April 2020

0 references

1 reference

28 October 2013

Microsoft Academic ID

2780692415

0 references

WikiProjectMed ID

Trimipramine

0 references

WordNet 3.1 Synset ID

04490655-n

1 reference